Rhabdoid

Rhabdoid describes a distinctive appearance of tumor cells under the microscope: large, round cells with an eccentric (off-center) nucleus and a dense pink "blob" of protein next to it. When a mesothelioma or other tumor contains many cells with this look, pathologists may call it a rhabdoid variant or note rhabdoid features. This appearance generally signals a more aggressive cancer.

Origin

The term comes from the Greek rhabdos, meaning "rod," combined with -oid meaning "resembling." It was first applied in the 1970s to describe pediatric kidney tumors whose cells resembled skeletal muscle (rhabdomyoblasts), and pathologists later borrowed the term for any tumor whose cells share that same eccentric-nucleus, dense-cytoplasm appearance.

Significance in Asbestos Context

In mesothelioma pathology reports, the words "rhabdoid features" or "rhabdoid variant" usually appear under the sarcomatoid or biphasic subtype and tend to indicate a more aggressive course and shorter survival than epithelioid mesothelioma without rhabdoid change. This detail can affect treatment recommendations, eligibility for certain clinical trials, and prognosis discussions with the medical team. For legal claims, the pathology subtype and any rhabdoid notation are part of the medical record used to document the diagnosis and its severity, so it is worth ensuring the final pathology report clearly states the subtype.

Example Sentence

After reviewing the pleural biopsy slides, the pathologist noted rhabdoid features within the sarcomatoid component, which her oncologist explained would influence the choice of systemic therapy.

Related Terms

Sarcomatoid Mesothelioma, Biphasic Mesothelioma, Epithelioid Mesothelioma, BAP1, Histology, Immunohistochemistry

Notes

• Ask your oncologist or pathologist whether your tumor shows rhabdoid features and, if so, what percentage of the tumor is affected. This can influence prognosis and treatment.
• Request a second pathology review at a mesothelioma specialty center (such as an NCI-designated cancer center) if rhabdoid features are mentioned, since this finding is uncommon and benefits from expert confirmation.
• Preserve the full pathology report, including any addenda and immunohistochemistry results, as part of your medical and legal file.
• Ask whether the rhabdoid component affects eligibility for clinical trials, immunotherapy, or other targeted treatments.